| Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis–a review P Prasanna, P Kumar, S Kumar, VK Rajana, V Kant, SR Prasad, U Mohan, ... Biomedicine & Pharmacotherapy 141, 111920, 2021 | 34 | 2021 |
| In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS) V Kant, S Vijayakumar, GC Sahoo, V Ali, K Singh, SS Chaudhery, P Das Journal of Biomolecular Structure and Dynamics 37 (2), 481-492, 2019 | 13 | 2019 |
| LeishInDB: a web-accessible resource for small molecule inhibitors against Leishmania sp S Vijayakumar, V Kant, P Das Acta tropica 190, 375-379, 2019 | 11 | 2019 |
| In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate … V Kant, P Kumar, R Ranjan, P Kumar, D Mandal, S Vijayakumar Parasitology Research 121 (7), 2093-2109, 2022 | 4 | 2022 |
| Designing of peptide and non-peptide inhibitors against leishmania cysteine-synthase (Ld-OASS) V Kant, G Sahoo, M Kumar, M Dikhit, S Sinha, P Das International Journal of Infectious Diseases 73, 301, 2018 | 3 | 2018 |
